Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.
about
Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarctionAntipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.
P2860
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Association of ADRA2A and MTHF ...... o aripiprazole or ziprasidone.
@en
Association of ADRA2A and MTHF ...... o aripiprazole or ziprasidone.
@nl
type
label
Association of ADRA2A and MTHF ...... o aripiprazole or ziprasidone.
@en
Association of ADRA2A and MTHF ...... o aripiprazole or ziprasidone.
@nl
prefLabel
Association of ADRA2A and MTHF ...... o aripiprazole or ziprasidone.
@en
Association of ADRA2A and MTHF ...... o aripiprazole or ziprasidone.
@nl
P2093
P2860
P356
P1476
Association of ADRA2A and MTHF ...... to aripiprazole or ziprasidone
@en
P2093
Ahmad Hatim
Mas Ayu Said
Nor Zuraida Zainal
Siti Norsyuhada Roffeei
Syarinaz Ahmad Aida
P2860
P356
10.1002/HUP.2366
P577
2013-11-25T00:00:00Z